// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The genetic architecture of hip statistical shape models suggests that endochondral bone formation makes an important contribution to hip shape

D. Baird - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Stratifying osteoarthritis using liquid chromatography-tandem mass spectrometry proteomic analysis of synovial fluid

J.R. Anderson - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Hyaluronidase

The effect of exercise on the protein profile of rat knee joint intra- and extra-articular ligaments

Y. Ashraf Kharaz - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acrocallosal syndrome

guanidine

Metabolomics and metabolic function analysis of the secretome of articular cartilage and isolated chondrocytes in response to pro-inflammatory cytokines

C. Fellows - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Interleukin

Combined LC-QTOF-MS urine metabolomics and 18F-NaF PET imaging indicates novel compounds associated with spine osteoarthropathy in the rare disease alkaptonuria

B.P. Norman - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Alkaptonuria

Nitisinone

Acute phase response signalling is altered following cartilage harvest in non-responders to autologous chondrocyte implantation

C.H. Hulme - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identifying load responsive synovial fluid metabolic markers following pivot-shift testing in ACL injury subjects

N. Khatib - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association of chemerin levels in serum and synovial fluid with the severity of hip osteoarthritis

A. Philp - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Hyaluronidase

Glucosepane: a new biomarker of the severity of osteoarthritis

U. Ahmed - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

Interleukin

Synovial fluid fingerprinting in end-stage knee osteoarthritis: a novel biomarker concept to assess disease modifying therapies

C. Jayadev - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Comprehensive expression analysis of small non coding RNAS in early osteoarthritis synovial fluid

M.J. Peffers - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Hyaluronidase

Adipokines production in metabolic-associated osteoarthritis of the knee joint

H.A. Haji Abd Kadir - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Metabolic syndrome

Progranulin

Assessment of candidate predictive protein biomarkers for microfracture and osteotomy

C.H. Hulme - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hyaluronic acid

Novel biomarkers for osteoarthritis are linked to pain sensitization, bone marrow lesions and cartilage damage

L. Assi - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

The effect of simvastatin on novel exploratory biomarkers of cartilage degradation

H. Quasnichka - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

guanidine

Prevalence and incidence of clinically diagnosed knee, hip and hand osteoarthritis in women with polycystic ovary syndrome: a National Register-Based Study

M.T. Sanchez-Santos - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Polycystic Ovary Syndrome

N/A

Post-surgical predictors of chronic pain after primary knee replacement

S. Khalid - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Urinary tract infections

N/A

Longitudinal validity of using digital photographs for assessing progression of hand osteoarthritis over 7 years in community-dwelling adults

M. Marshall - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis 2

N/A

Impact of a national enhanced recovery programme on patient outcomes of primary total and unicomparmental knee replacement: 2008–2016 England trends

C. Garriga - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Development of a prediction model for hip replacement amongst former Elite Rugby players

M.A. Davies - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved